SGLT2 Inhibitors Similarly, SGLT2 inhibitors offer a distinct but partially overlapping metabolic benefit that may be especially relevant to the energetically vulnerable aging brain
By calming this chronic inflammation, GLP-1s can support better insulin sensitivity, hormone balance, and overall metabolic health
We recognize the dual benefits of these medications, not only in improving glycemic control but also in aiding weight loss by promoting satiety and slowing gastric emptying
No clinical trials have specifically investigated this combination, and the interactions discussed below remain theoretical
Lexaria will provide more details about its GLP-1 strategy in separate news
What we are seeing is a signal that it may slow some of the biological processes associated with aging. Around 30 million Americans are taking GLP-1s to aid weight loss along with other conditions including diabetes and cardiovascular disease